Molecular cloning of the cDNA coding sequence of IL-2 receptor-γ (γ(c)) from human and murine forebrain: Expression in the hippocampus in situ and by brain cells in vitro

Molecular Brain Research

Volumn 53, Issue 1-2, 1998, Pages 152-162

  Petitto, John M ^a   Huang, Zhi ^a   Raizada, Mohan K ^a   Rinker, Craig M ^a   McCarthy, Denis B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Cytokine receptors; In situ; Interleukin 2; Molecular cloning; Neurobiology

Indexed keywords

BRAIN RECEPTOR; COMPLEMENTARY DNA; CYTOKINE RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; RECEPTOR SUBUNIT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN NERVE CELL; CODON; CONTROLLED STUDY; DENTATE GYRUS; DNA SEQUENCE; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LYMPHOCYTE; MALE; MOLECULAR CLONING; MOUSE; NEUROBIOLOGY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; SPLEEN;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HIPPOCAMPUS; HUMANS; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; NEUROGLIA; NEURONS; PROSENCEPHALON; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPLEEN;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; MAMMALIA; MURINAE;

EID: 0031908963     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00276-3     Document Type: Article

References (81)

1. Alonso R., Chaudieu I., Diorio J., Krishnamurthy A., Quirion R., Boska P. Interleukin-2 modulates evoked release of [3H]dopamine in cultured rat mesencephalic cells. J. Neurochem. 61:1993;1284-1290.
2. Araujo D.M., Lapchak P.A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience. 61:1994;745-754.
3. D.M. Araujo, P.A. Lapchak, J.G. Chabot, N.P. Nair, R. Quirion, Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. In Alzheimer's Disease and Related Disorders, Liss, New York, 1989 pp. 423-436.
4. Araujo D.M., Lapchak P.A., Collier B., Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 498:1989;257-266.
5. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidmann, J.A. Smith, K. Struhl (Eds.), Current Protocols in Molecular Biology, Greene, New York, NY, 1997.
6. Awatsuji H., Furukawa Y., Nakajima M., Furukawa S., Hayashi K. Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J. Neurosci. Res. 35:1993;305-311.
7. Balasingam V., Tejada Berges T., Wright E., Bouckova R., Yong V.W. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14:1994;846-856.
8. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA. 87:1990;6934-6938.
9. Benveniste E.N., Herman P.K., Whitaker J.N. Myelin basic protein-specific RNA levels in interleukin-2-stimulated oligodendrocytes. J. Neurochem. 49:1987;1274-1279.
10. Benveniste E.N., Merrill J.E. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature. 321:1986;610-613.
11. Benveniste E.N., Tozawa H., Gasson J.C., Quan S., Golde D.W., Merrill J.E. Response of human glioblastoma cells to recombinant interleukin-2. J. Neuroimmunol. 17:1988;301-314.
12. Benveniste E.N., Whitaker J.N., Gibbs D.A., Sparacio S.M., Butler J.L. Human B cell growth factor enhances proliferation and glial fibrillary acidic protein gene expression in rat astrocytes. Int. Immunol. 1:1989;219-228.
13. Bianchi M., Panerai A.E. Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse. Neuroreport. 4:1993;1046-1048.
14. Bosma G.C., Cluster R.P., Bosma M.J. A severe combined immunodeficiency in the mouse. Nature. 301:1989;527-531.
15. Brown S.L., Smith L.R., Blalock J.E. Interleukin-1 and interleukin-2 enhance proopiomelanocortin gene expression in pituitary cells. J. Immunol. 139:1987;3181-3183.
16. Cao X., Kozak C.A., Liu Y.J., Noguchi M., O'Connell E., Leonard W.J. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) γ chain: chromosomal mapping and tissue specificity of IL-2R γ chain expression. Proc. Natl. Acad. Sci. USA. 90:1993;8464-8468.
17. Eitan S., Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science. 261:1993;106-108.
18. Eizenberg O., Faber-Elman A., Lotan M., Schwartz M. Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem. 64:1995;928-1936.
19. W.L. Farrar, Endorphin modulations of lymphokine activity. In F. Fraioli, A. Isidori, M. Mazzetti (Eds.), Opioid Peptides in the Periphery, Elsevier, Amsterdam, 1984, pp. 159-165.
20. Gaffen R., Lai S.Y., Ha M., Liu X., Henninghausen L., Greene W.C., Goldsmith M.A. Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy and diversity. J. Biol. Chem. 271:1996;21381-21390.
21. Ganguli R., Brar J.S., Chengappa K.N., DeLeo M., Yang Z.W., Shurin G., Rabin B.S. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients: the influence of age at onset and negative symptoms. Arch. Gen. Psychiatry. 52:1995;668-678.
22. Ganguli R., Rabin B.S. Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects [letter]. Arch. Gen. Psychiatry. 46:1989;292.
23. Hanisch U.-K., Lyons S., Kirchhoff F., Nolte C., Kettenmann H. Expression of a functional interleukin-15 receptor complex by microglial cells in culture. Soc. Neurosci. Abs. 22:1996;849.
24. Hanisch U.-K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:1996;246-284.
25. Hanisch U.-K., Seto D., Quirion R. Modulation of hipppocampal acetylcholine release: potent central action of interleukin-2. J. Neurosci. 13:1993;3368-3374.
26. Hoffman F.M., Von Hanwehr R.I., Dinarello C.A., Mizel S.B., Hinton D., Merrill J.E. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136:1986;3239-3245.
27. Huberman M., Shalit F., Roth-Deri I., Gutman B., Kott E., Sredni B. Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis. J. Neurol. Sci. 118:1993;79-82.
28. Hunter K.E., Sporn M.B., Davies A.M. Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes. Glia. 7:1993;203-211.
29. Kluter H., Vieregge P., Stolze H., Kirchner H. Defective production of interleukin-2 in patients with idiopathic Parkinson's disease. J. Neurol. Sci. 133:1995;134-139.
30. Kobayashi N., Nakagawa S., Minami Y., Taniguchi T., Kono T. Cloning and sequencing of the cDNA encoding a mouse IL-2 receptor gamma. Gene. 130:1993;303-304.
31. Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science. 262:1993;1874-1877.
32. Krissansen G.W., Owen M.J., Fink P.J., Crumpton M.J. Molecular cloning of the cDNA of the encoding the T3γ subunit of the mouse T3/T cell antigen receptor complex. J. Immunol. 138:1987;3513-3518.
33. Kumaki S., Kondo M., Takeshita T., Asao H., Nakamura M., Sugamura K. Cloning of the mouse interleukin 2 receptor γ chain: demonstration of functional differences between the mouse and human receptors. Biochem. Biophys. Res. Commun. 193:1993;356-363.
34. Lapchak P.A. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport. 3:1992;165-168.
35. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience. 44:1991;173-184.
36. Lee H.J., Hammond D.N., Large T.H., Roback J.D., Sim J.A., Brown D.A., Otten U.H., Wainer B.H. Neuronal properties and trophic activities of immortalized hippocampal cells from embryonic and young adult mice. J. Neurosci. 10:1990;1779-1787.
37. Licinio J., Seibyl J.P., Altemus M., Charney D.S., Krystal J.H. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry. 150:1993;1408-1410.
38. Luber-Narod J., Rogers J. Immune system associated antigens expressed by cells of the human central nervous system. Neurosci. Lett. 94:1988;17-22.
39. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29:1995;141-152.
40. Maes M., Meltzer H.Y., Buckley P., Bosmans E. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur. Arch. Psychiatry Clin. Neurosci. 244:1995;325-329.
41. McAllister C.G., van-Kammen D.P., Rehn T.J., Miller A.L., Gurklis J., Kelley M.E., Yao J., Peters J.L. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am. J. Psychiatry. 152:1995;1291-1297.
42. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79:1987;195-200.
43. Mennicken F., Bastianetto S., Quirion R. Interleukin-15 (IL-15) induces toxicity in mesencephalic, septal and hippocampal neuronal cell cultures. Soc. Neurosci. 22:1996;849.
44. Merrill J.E. Interleukin-2 effects in the central nervous system. Ann. NY Acad. Sci. 594:1990;188-199.
45. Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11:1993;245-268.
46. Nemni R., Iannaccone S., Quattrini A., Smirne S., Sessa M., Lodi M., Erminio C., Canal N. Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice. Brain Res. 591:1992;248-252.
47. Nieto-Sampedro M., Chandy K.G. Interleukin-2-like activity in injured rat brain. Neurochem. Res. 12:1987;723-727.
48. Noguchi M., Adelstein S., Cao X., Leonard W.J. Characterization of the human interleukin-2 receptor gamma chain gene. J. Biol. Chem. 268:1993;13601-13608.
49. Olson J.A., Shiverick K.T., Buhi W.C., Ogiliv S., Raizada M.K. Angiotensin II induces secretion of plasminogen activator inhibitor-1 and tissue metalloprotease inhibitor-related protein from rat brain astrocytes. Proc. Natl. Acad. Sci. USA. 88:1991;1928-1932.
50. Otero G.C., Merrill J.E. Molecular cloning of IL-2Rα, IL-2Rβ, and IL-2Rγ cDNA from a human oligodendroglioma cell line: presence of IL-2R mRNAs in the human central nervous system. Glia. 14:1995;295-302.
51. Petitto J.M., Huang Z. Molecular cloning of the coding sequence of an interleukin-2 receptor α subunit cDNA in murine brain. J. Neuroimmunol. 59:1995;135-141.
52. Petitto J.M., Huang Z. Molecular cloning of a partial cDNA of the interleukin-2 receptor-β in normal mouse brain: in situ localization in the hippocampus and expression by neuroblastoma cells. Brain Res. 650:1994;140-145.
53. 125I] NPY binding sites. J. Neuroimmunol. 54:1994;81-86.
54. Petitto J.M., McCarthy D.B., Rinker C.M., Huang Z., Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73:1997;183-190.
55. Plata-Salaman C.R., ffrench-Mullen J.M. Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons. Neuroreport. 4:1993;579-581.
56. 125I]insulin to specific receptors and stimulation of nucleotide incorporation in cells cultured from rat brain. Brain Res. 200:1980;389-400.
57. Rapaport M.H., Torrey E.F., McAllister C.G., Nelson D.L., Pickar D., Paul S.M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur. Arch. Psychiatry Clin. Neurosci. 243:1993;7-10.
58. Renno T., Lin J.-Y., Piccirillo C., Antel J., Owens T. Cytokine production by cells in the cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1994;1-7.
59. Rickman M., Amaral D.G., Cowan W.M. Organization of radial glial cells during the development of the rat dentate gyrus. J. Comp. Neurol. 264:1987;449-479.
60. Ronnett G.V., Hester L.D., Nye J.S., Snyder S.H. Human cerebral cortical cell lines from patients with unilateral megalencephaly and Rasmussen's encephalitis. Neuroscience. 63:1994;1081-1099.
61. Rydzewski B., Zelezna B., Tang W., Sumners C., Raizada M.K. Angiotensin II stimulation of plasminogen activator inhibitor-1 gene expression in astroglial cells from the brain. Endocrinology. 130:1992;1255-1262.
62. Saneto R.P., Altman A., Knobler R.L., Johnson H.M., de Vellis J. Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc. Natl. Acad. Sci. USA. 83:1986;9221-9225.
63. Sarder M., Saito H., Abe K. Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Res. 625:1993;347-350.
64. Sawada M., Suzumura A., Marunouchi T. Induction of functional interleukin-2 receptor in mouse microglia. J. Neurochem. 64:1995;1973-1979.
65. Selmaj K., Raine C.S., Farooq M., Norton W.T., Brosnan C.F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
66. Sessa M., Nemni R., Iannaccone S., Quattrini A., Confalonieri V., Canal N. In vivo modulation of myelin gene expression by human recombinant IL-2. Brain Res. Mol. Brain Res. 12:1992;331-334.
67. Shimojo M., Imai Y., Nakajima K., Mizushima S., Uemura A., Kohsaka S. Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci. Lett. 151:1993;170-173.
68. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
69. Singh V.K. Studies of neuroimmune markers in Alzheimer's diseas. Mol. Neurobiol. 9:1994;73-81.
70. Smith L.R., Brown S.L., Blalock J.E. Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells. J. Neuroimmunol. 21:1989;249-254.
71. Sumners C., Tang W., Zelezna B., Raizada M.K. Angiotensin II receptor subtypes are couple with distinct signal transduction mechanisms in cultured neurons and astroglia from rat brain. Proc. Natl. Acad. Sci. USA. 88:1990;7567-7571.
72. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the γ chain of the human IL-2 receptor. Science. 257:1993;379-382.
73. Tancredi V., Zona C., Velotti F., Eusebi F., Santoni A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res. 525:1990;149-151.
74. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 268:1995;251-255.
75. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 73:1993;5-8.
76. Villemain F., Chatenoud L., Galinowski A., Homo Delarche F., Ginestet D., Loo H., Zarifian E., Bach J.F. Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am. J. Psychiatry. 146:1989;609-616.
77. Watson D.G., Wainer B.H., Lenox R.H. Phorbol ester- and retinoic acid-induced regulation of the protein kinase C substrate MARCKS in immortalized hippocampal cells. J. Neurochem. 63:1994;1666-1674.
78. Weissman A.M., Hou D., Orloff D.G., Modi W.S., Seuanez H., O'Brein S.J., Klaausner R.D. Molecular cloning and chromosomal localization of the human T-cell receptor ζ chain: distinction from the molecular CD3 complex. Proc. Natl. Acad. Sci. USA. 85:1988;9705-9713.
79. Woodroofe M.N., Bellamy A.S., Feldmann M., Davison A.N., Cuzner M.L. Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J. Neurol. Sci. 74:1986;135-152.
80. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine specific central monoamine alterations induced by interleukin-1, -2, and -6. Brain Res. 643:1994;40-49.
81. Zwain I.H., Grima J., Cheng C.Y. Regulation of clusterin secretion and mRNA expression in astrocytes by cytokines. Mol. Cell. Neurosci. 5:1994;229-237.